# Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis

> **NCT02565732** · PHASE2 · COMPLETED · sponsor: **Revance Therapeutics, Inc.** · enrollment: 67 (actual)

## Conditions studied

- Hyperhidrosis

## Interventions

- **BIOLOGICAL:** Botulinum toxin type A
- **BIOLOGICAL:** Botulinum toxin type A
- **BIOLOGICAL:** Placebo comparator

## Key facts

- **NCT ID:** NCT02565732
- **Lead sponsor:** Revance Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2015-12
- **Final completion:** 2016-01
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2016-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02565732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02565732, "Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02565732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*